Investors.beamtx.com

Press Releases Beam Therapeutics

WEBCAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines …

Actived: 3 days ago

URL: https://investors.beamtx.com/press-releases

Beam Therapeutics Presents First In Vivo Data Demonstrating …

WEB“Chronic HBV infection remains a major global health problem, and despite available antiviral medications, there is a significant need for a treatment that can both …

Category:  Health Go Health

Beam Therapeutics Announces Preclinical Data Highlighting …

WEB“Hepatitis B is a major global health crisis, with more than 250 million people currently diagnosed with chronic disease worldwide. Despite current therapeutic …

Category:  Health Go Health

Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In …

WEBBeam to Receive $250 Million in Combined Upfront Payment and Equity Investment, Expected to Extend Beam’s Cash Runway to the Second Half of 2026 …

Category:  Health Go Health

Beam Therapeutics Announces First Patient Dosed in Phase 1/2 …

WEBBEAM-201 Represents First Quadruplex-edited, Allogeneic CAR-T Cell Therapy Candidate in Clinical-stage Development and First Treatment with a Base …

Category:  Health Go Health

Beam Therapeutics Presents Preclinical Data Highlighting Utility of

WEBEach forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or implied in …

Category:  Health Go Health

Beam Therapeutics Presents Preclinical Data Highlighting Utility …

WEBSingle Dose of BEAM-301 Restored Clinically Meaningful Endpoints in In Vivo Rodent Disease Models Out to at Least One Year Company Plans to Submit U.S. …

Category:  Health Go Health

Beam Therapeutics Reports Pipeline Updates and First Quarter …

WEBEach forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or …

Category:  Health Go Health

Pfizer and Beam Enter Exclusive Multi-Target

WEBConsistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments …

Category:  Health Go Health

Beam Therapeutics Reports Pipeline and Business Updates and …

WEBRecent Portfolio Prioritization Focuses Business on Key Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline. Lilly Acquires …

Category:  Medicine Go Health

Beam Therapeutics Announces Portfolio Prioritization and …

WEBHighest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for …

Category:  Health Go Health

Beam Therapeutics Highlights Progress Across Base Editing …

WEBEach forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or implied in …

Category:  Health Go Health

Beam Therapeutics Announces Business and Pipeline Progress and …

WEBLeading Healthcare Executive, Kate Walsh, Appointed to Board of Directors: In January 2021, Kate Walsh, president and chief executive officer of the Boston …

Category:  Health Go Health

Beam Therapeutics Announces Pipeline and Business Highlights …

WEBThis research is designed to establish an understanding of the hematologic and clinical phenotype of people with sickle cell trait, including blood rheology, potential …

Category:  Health Go Health

Beam Therapeutics

WEBSingle base DNA variants drive health outcomes Common disease Single base changes drive risk and protection from common diseases Rare disease Over half of genetic …

Category:  Health Go Health

Beam Therapeutics Reports Fourth Quarter and Year-End 2022 …

WEBEach forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or …

Category:  Health Go Health

Beam Therapeutics to Participate in Upcoming March 2024 …

WEBCAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines …

Category:  Medicine Go Health

Beam Therapeutics Appoints Biotech Executive Christi Shaw to its …

WEBCAMBRIDGE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines …

Category:  Medicine Go Health

TD Cowen 44th Annual Health Care Conference, Emerging Genetic …

WEBTD Cowen 44th Annual Health Care Conference, Emerging Genetic Therapy Approaches Corporate Panel Discussion: March 06, 2024 at 12:50 PM EST Listen to …

Category:  Health Go Health

PRECISION GENETIC MEDICINES THROUGH BASE EDITING

WEBenforce patent and other intellectual property protection for our product candidates; the potential impact of pandemics and other health emergencies, including their impact on …

Category:  Health Go Health